Consumer Complaint Analysis

What it extracts

14 extraction fields

Complaint Overview

A one-look roll-up of the complaint's spine - reference, date received, intake channel, reporter type, market of report, product category, a neutral summary, and status - so a handler can orient before working the case.

Product & Batch Identification

The traceability fields a quality investigation depends on - generic product description and category, batch/lot number, manufacturing and expiry/PAO dates, product code, purchase channel, and units affected - with an explicit flag for whether a batch was captured, since a missing batch blocks investigation and recall.

Complaint Category

Assigns the single standardized top-level category (adverse reaction, contamination/foreign material, quality defect, packaging defect, sensory/aesthetic, efficacy shortfall, labeling, counterfeit/tampering, or other) that routes the case and drives trending, choosing the most safety-significant when several apply.

Complaint Detail Breakdown

Decomposes a multi-issue complaint into one row per distinct issue - sub-category, description, affected attribute, consumer-reported impact, and a short verbatim excerpt - so nothing is collapsed away and each issue can be trended.

Sensory & Aesthetic Assessment

Characterizes each sensory or aesthetic dissatisfaction (odor/fragrance, texture, oiliness/greasiness, pilling, absorption, color, feel) against the intended profile, so R&D can tell a reformulation issue from a consumer-expectation one; excludes health reactions.

Efficacy & Performance Assessment

Captures a did-not-work complaint - the benefit at issue, the reported shortfall, usage duration and compliance, and a read of whether it is a real performance issue, a usage issue, or an expectation gap beyond the product's claim.

Adverse Event Assessment

The cosmetovigilance core - whether a health effect was reported and, if so, the reaction type, body site, onset/latency, duration and course, clinical severity, medical attention, outcome, and confounders needed to judge causality and seriousness.

Adverse Event Classification

Classifies the case as not an adverse event, a non-serious undesirable effect, a serious undesirable effect / serious adverse event, or insufficient information - per EU Regulation (EC) 1223/2009 Art. 2 and the MoCRA / FD&C §605 serious-adverse-event criteria - erring toward serious when seriousness cannot be excluded.

Severity & Priority Triage

Rolls category, adverse-event classification, and batch context into a single handling priority (critical / high / medium / low / informational), choosing the most severe level that applies so the case is worked at the right urgency.

Regulatory Reportability

A first-pass safety screen - true when the case is a serious undesirable effect / serious adverse event (or seriousness cannot be excluded), because that triggers a MoCRA 15-business-day FDA report in the US or an Article 23 SUE notification to the competent authority in the EU; false for non-serious and non-adverse-event complaints.

Regulatory Reporting Assessment

Explains the reportability screen - the applicable regime (US MoCRA §605, EU CPR Art. 23, other market, or none), report type, the reporting deadline as reviewer guidance, the responsible function, and the rationale tied to the seriousness criteria and any missing information.

Root Cause Signals

A preliminary root-cause read that directs the investigation - the likely cause domain (formulation, manufacturing/fill, packaging, storage, supplier, counterfeit, misuse, expectation gap), whether a batch defect is implicated, the hypothesis, the evidence/retained-sample needed, and whether CAPA is warranted.

Trend & Frequency Signal

Places the single complaint in the wider pattern that turns individual complaints into a quality or safety signal - per trend dimension (category rate, batch/product concentration, reaction cluster, sensory/efficacy theme, geography), what this complaint contributes, the signal to monitor, and a recommended escalation threshold.

Complaint Handling Summary & Recommended Actions

The handler narrative - product and complaint, whether a health effect was reported and how it classified, severity and reportability, the root-cause read, and the recommended consumer-resolution, investigation/containment, and cosmetovigilance hand-off actions, closing with the one thing to confirm before closing the case.

Where it fits

What it needs

What it produces

Review model

A qualified complaint handler, and for any reaction a cosmetovigilance / product-safety reviewer, confirms the category, the adverse-event and seriousness calls, and the reportability screen before a case is closed or a report is filed. Every output is a first-pass recommendation, not a regulatory filing decision or a clinical diagnosis.

Who uses it

Volume fit

Grounded in

• Modernization of Cosmetics Regulation Act of 2022 (MoCRA), FD&C Act Section 605 - serious adverse event reportingverified as of 2026-07-22
• Regulation (EC) No 1223/2009 on cosmetic products - Article 2 (definitions) and Article 23 (communication of serious undesirable effects)verified as of 2026-07-22
• Cosmetics Europe - Guidelines on the Management of Undesirable Effects and Reporting of Serious Undesirable Effects (cosmetovigilance)verified as of 2026-07-22
• ISO 22716 - Cosmetics Good Manufacturing Practices (GMP) - complaints, recalls, and batch traceabilityverified as of 2026-07-22

Changelog

• July 2026